Deep venous thrombosis

L Duffett - Annals of internal medicine, 2022 - acpjournals.org
Venous thromboembolism (VTE) is the third most common cardiovascular disorder, affecting
up to 5% of the population. VTE commonly manifests as lower-extremity deep venous …

Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline

JD Douketis, AC Spyropoulos, MH Murad, JI Arcelus… - Chest, 2022 - Elsevier
Background The American College of Chest Physicians Clinical Practice Guideline on the
Perioperative Management of Antithrombotic Therapy addresses 43 Patients-Interventions …

[HTML][HTML] Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

EJ Favaloro, L Pasalic - Research and Practice in Thrombosis and …, 2022 - Elsevier
Background Lupus anticoagulants (LA) are one laboratory criterion for classification of
antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal …

[HTML][HTML] The impact of direct oral anticoagulants on viscoelastic testing–A systematic review

SD Sahli, C Castellucci, TR Roche, J Rössler… - Frontiers in …, 2022 - frontiersin.org
Background In case of bleeding patients and in acute care, the assessment of residual direct
oral anticoagulant (DOAC) activity is essential for evaluating the potential impact on …

[HTML][HTML] The myths behind DOAC measurement: analyses of prescribing information from different regulatory bodies and a call for harmonization

RC Gosselin, EJ Favaloro, J Douxfils - Journal of Thrombosis and …, 2022 - Elsevier
For more than a decade, US laboratories have failed to implement solutions to help their
clinicians in managing complex situations or patients on direct oral anticoagulants (DOACs) …

[HTML][HTML] DOAC dipstick testing can reliably exclude the presence of clinically relevant DOAC concentrations in circulation

S Margetić, I Ćelap, AL Huzjan… - Thrombosis and …, 2022 - thieme-connect.com
In certain clinical situations, it is necessary to determine whether clinically relevant plasma
levels of direct oral anticoagulants (DOACs) are present. We examined whether qualitative …

An overview of heparin monitoring with the anti-Xa assay

CL Dean - Hemostasis and Thrombosis: Methods and Protocols, 2023 - Springer
Heparin remains a critical therapy in hospitalized patients requiring anticoagulation.
Unfractionated heparin (UFH) mediates its therapeutic effect by binding to antithrombin (AT) …

The value and limitations of new oral anticoagulant plasma level assessments

L Van der Linden, J Hias… - European Heart Journal …, 2022 - academic.oup.com
abstract The class of new oral anticoagulants (NOACs) has been developed to provide
reliable oral anticoagulation without the need for therapeutic drug monitoring. Based on …

Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper

J Harenberg, RC Gosselin, A Cuker… - Thrombosis and …, 2024 - thieme-connect.com
Background With the widespread use of direct oral anticoagulants (DOACs), there is an
urgent need for a rapid assay to exclude clinically relevant plasma levels. Accurate and …

[HTML][HTML] The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review

A Frackiewicz, B Kalaska, J Miklosz, A Mogielnicki - Thrombosis Journal, 2023 - Springer
The assessment of hemostasis is necessary to make suitable decisions on the management
of patients with thrombotic disorders. In some clinical situations, for example, during …